Guerra Advisors’s Edwards Lifesciences EW Stock Holding History

Guerra Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$5.05K	Buy	+65	New	+$5.08K	﹤0.01%	401

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Guerra Advisors's EW Position: Q3 2025 in Review

Guerra Advisors opened a new position in Edwards Lifesciences (EW) in Q3 2025: 65 shares worth $5.05K. The stake represents ﹤0.01% of the portfolio and ranks #401 among its holdings.

1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Guerra Advisors held 65 shares of Edwards Lifesciences worth $5.05K as of Q3 2025.
Edwards Lifesciences was a new Guerra Advisors position in Q3 2025.
Edwards Lifesciences made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #401 holding.
1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.